Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

  • Showing results for a modified search because your search retrieved no results.
1.

Safety of hospital discharge before return of bowel function after elective colorectal surgery.

EuroSurg Collaborative.

Br J Surg. 2020 Jan 24. doi: 10.1002/bjs.11422. [Epub ahead of print]

PMID:
31976560
2.

Global variation in anastomosis and end colostomy formation following left-sided colorectal resection.

GlobalSurg Collaborative; Writing group; Patient representatives; Statistical analysis; Protocol development and project steering; National leads (GlobalSurg‐1); National leads (GlobalSurg‐2); Local collaborators (GlobalSurg‐1); Local collaborators (GlobalSurg‐2); Data validators (GlobalSurg‐2); Protocol translators (GlobalSurg‐2).

BJS Open. 2019 Feb 28;3(3):403-414. doi: 10.1002/bjs5.50138. eCollection 2019 Jun.

3.

Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery.

EuroSurg Collaborative.

Br J Surg. 2020 Jan;107(2):e161-e169. doi: 10.1002/bjs.11326. Epub 2019 Oct 9.

PMID:
31595986
4.

Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy.

GlobalSurg Collaborative.

Br J Surg. 2019 Jan;106(2):e103-e112. doi: 10.1002/bjs.11051.

5.

Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY.

Bernabeu I, Pico A, Venegas E, Aller J, Alvarez-Escolá C, García-Arnés JA, Marazuela M, Jonsson P, Mir N, García Vargas M; Spanish ACROSTUDY Group.

Pituitary. 2016 Apr;19(2):127-37. doi: 10.1007/s11102-015-0691-0. Erratum in: Pituitary. 2016 Aug;19(4):460.

PMID:
26553421
6.

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.

Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK; DYSIS investigators.

Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x.

PMID:
21679231
7.

Inhaled drugs as risk factors for community-acquired pneumonia.

Almirall J, Bolíbar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A; Community-Acquired Pneumonia in Catalan Countries.

Eur Respir J. 2010 Nov;36(5):1080-7. doi: 10.1183/09031936.00022909. Epub 2010 Jun 4.

8.

[HER2/neu expression in Venezuelan patients with locally advanced breast cancer].

Morales L, Reigosa A, Caleiras E, Mora R, Marrero N, Payares E, Molina K, Sucre L.

Invest Clin. 2008 Mar;49(1):69-78. Spanish.

PMID:
18524333
9.

New evidence of risk factors for community-acquired pneumonia: a population-based study.

Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A; Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group.

Eur Respir J. 2008 Jun;31(6):1274-84. doi: 10.1183/09031936.00095807. Epub 2008 Jan 23.

Supplemental Content

Loading ...
Support Center